In SLE, one study addressed its effects in atherosclerosis and concluded that serum levels were greater in these patients than in controls; in addition, endocan levels correlated positively with cIMT (r = 0.469, p < 0.01) (80). The gene discussed is ESM1; the disease is systemic lupus erythematosus.